Airway clearance techniques in patients with bronchiectasis. Data from the EMBARC Registry.

A. Spinou (London, United Kingdom), S. Aliberti (Milan, Italy), R. Menendez (Valencia, Spain), F. Blasi (Milan, Italy), P. Regis-Burgel (Paris, France), F. Ringshausen (Hannover, Germany), A. De Soyza (Newcastle upon Tyne, United Kingdom), M. Shteinberg (Haifa, Israel), A. Shoemark (Dundee, United Kingdom), M. Vendrell (Girona, Spain), E. Polverino (Barcelona, Spain), C. Haworth (Cambridge, United Kingdom), K. Dimakou (Athens, Greece), M. Loebinger (London, United Kingdom), A. Torres (Barcelona, Spain), T. Welte (Hannover, Germany), S. Elborn (Belfast, United Kingdom), P. Goeminne (Sint-Niklaas, Belgium), J. Chalmers (Dundee, United Kingdom), B. Herrero-Cortina (Zaragoza, Spain)

Source: Virtual Congress 2020 – New insights into respiratory physiotherapy
Session: New insights into respiratory physiotherapy
Session type: E-poster session
Number: 1263
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Spinou (London, United Kingdom), S. Aliberti (Milan, Italy), R. Menendez (Valencia, Spain), F. Blasi (Milan, Italy), P. Regis-Burgel (Paris, France), F. Ringshausen (Hannover, Germany), A. De Soyza (Newcastle upon Tyne, United Kingdom), M. Shteinberg (Haifa, Israel), A. Shoemark (Dundee, United Kingdom), M. Vendrell (Girona, Spain), E. Polverino (Barcelona, Spain), C. Haworth (Cambridge, United Kingdom), K. Dimakou (Athens, Greece), M. Loebinger (London, United Kingdom), A. Torres (Barcelona, Spain), T. Welte (Hannover, Germany), S. Elborn (Belfast, United Kingdom), P. Goeminne (Sint-Niklaas, Belgium), J. Chalmers (Dundee, United Kingdom), B. Herrero-Cortina (Zaragoza, Spain). Airway clearance techniques in patients with bronchiectasis. Data from the EMBARC Registry.. 1263

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Asthma as a co-morbidity and cause of bronchiectasis: data from the European Bronchiectasis Registry (EMBARC).
Source: Virtual Congress 2020 – Non-tuberculous mycobacterial infections and bronchiectasis
Year: 2020


Management of bronchiectasis in Europe: Data from the European bronchiectasis registry (EMBARC)
Source: International Congress 2016 – Clinical update on bronchiectasis
Year: 2016

Lung volume reduction coils (LVR-coils) for pulmonary emphysema: Results of the Italian National registry
Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going?
Year: 2013

Characteristics of severe asthmatics treated with omalizumab, mepolizumab or no biotherapy. Data from the Belgian Severe Asthma Registry (BSAR).
Source: International Congress 2019 – Exacerbations and clinical impact of airway diseases
Year: 2019



Chest physiotherapy in European patients with bronchiectasis: Data from the EMBARC registry
Source: International Congress 2017 – Bronchiectasis and NTM infections: epidemiology, phenotyping and therapeutic strategies
Year: 2017


Heterogeneity in bronchiectasis service provision in Europe: Baseline data from the European bronchiectasis registry (EMBARC)
Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook
Year: 2015

Cross-sectional analysis of the Belgian severe asthma registry (BSAR)
Source: International Congress 2014 – Direct and indirect monitoring of comorbidities
Year: 2014


Endoscopic lung volume reduction with endobronchial valves in patients with chronic hypercapnic respiratory failure: current data from the national Lung Emphysema Registry (LE-R) in Germany
Source: Virtual Congress 2021 – Pleural disease and bronchoscopic lung volume reduction
Year: 2021


Airway clearance techniques in bronchiectasis
Source: International Congress 2015 – Bronchiectasis in Europe: an update from the European Bronchiectasis Network (EMBARC)
Year: 2015



Interstitial lung diseases: Data analysis from a Portuguese respiratory reference hospital
Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease
Year: 2010

Inhaled corticosteroids use in patients with bronchiectasis: Data from the EMBARC registry
Source: Virtual Congress 2021 – Bronchiectasis heterogeneity: assessing the endotypes
Year: 2021



Lung clearance index in pediatric patients with asthma
Source: Annual Congress 2013 –Asthma treatment and management in children
Year: 2013


Airway obstruction by GOLD and ATS/ERS2005 criteria in Caucasian American pulmonary laboratory patients using NHANESIII and ERS/GLI12 prediction equations
Source: International Congress 2014 – The impact of the Global Lung Initiative (GLI) reference equations and spirometry quality in all ages
Year: 2014

Clinical trials for elderly patients with multiple diseases (CHROMED): A pilot study
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014

Lower rate of COPD exacerbations in patients with COPD and concurrent lung carcinoma – Data from the Bergmannsheil cohort
Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations
Year: 2015

Double-tracer gas washout in stable asthma and COPD
Source: International Congress 2014 – Monitoring airway diseases with lung function tests
Year: 2014


Sputum processing methods in airway disease: Which is best?
Source: International Congress 2014 – Airway biomarkers
Year: 2014

Disease progression in IPF assessed using pulmonary function tests and functional respiratory imaging (FRI) – A pilot study
Source: International Congress 2014 – COPD and PAH related imaging
Year: 2014


Outcome of surgical and endoscopic lung volume reduction with valves in patients with severe lung emphysema: current data of 246 patients with 3 months follow-up from a Lung Emphysema Registry in Germany
Source: Virtual Congress 2020 – Challenging issues in thoracic surgery
Year: 2020




Severity of airway obstruction in overweight/obese patients with chronic obstructive pulmonary disease(COPD)
Source: International Congress 2014 – Monitoring airway diseases with lung function tests
Year: 2014